Novo, Upping the Ante in the Race for an Oral GLP-1 Drug, Tests a Pill Version of Victoza
February 1, 2010, 1:00 pm
Denmark-based Novo Nordisk has begun a Phase 1 trial of a pill form of a GLP-1 drug very similar to its Victoza product. The trial will involve 155 British patients with type 2 diabetes. The test on human subjects, although very early-stage, puts the company in the lead to develop an oral form of a GLP-1 drug.
Read more...
Source
